Flow cytometry (FCM) is a useful adjunct to cytologic examination, bec
ause the quantitative biochemical information it provides complements
the morphologic information gained during visual examination. Tt aids
in the interpretation of bladder washings, and is particularly useful
for the assessment of lymphoid lesions, whether they originate from fi
ne-needle aspiration cerebrospinal fluid, or effusions. Optimal use of
FCM frequently requires assessment of more than one parameter; simult
aneous use of cell differentiation markers and nuclear DNA quantitatio
n is often significantly more useful than either alone. Despite the ut
ility of FCM, however, the potential for future development appears to
be limited Improvements in image cytometry allow reasonable assessmen
t of ploidy and S-fraction to be made from specimens prepared on glass
slides. Multiparameter measurements may also be accomplished with ima
ging techniques, which allow the further advantage of visual identific
ation of cells with equivocal morphologic changes. The development of
artificial intelligence methods for use with imaging technology has al
so significantly exceeded that of FCM. Finally, image cytometry is oft
en mole useful for samples with few cells. Other challenges are posed
by immunocytochemical methods which compete with flow cytometry as too
ls for assessment of proliferation. Given the relatively high cost of
FCM instrumentation, survival of FCM as an ancillary technique in cyto
pathology will require further technical refinements to offset the adv
antages currently associated with image cytometry and immunocytochemis
try. (C) 1998 Wiley-Liss, Inc.